Thermogenesis announces immunecyte joint venture acquires key technologies to develop fully human polyclonal and monoclonal antibody therapeutics for covid-19

Thermogenesis announces its immunecyte joint venture acquires key technologies to develop fully human polyclonal and monoclonal antibody therapeutics for covid-19.

THMO Ratings Summary

THMO Quant Ranking